This webinar will provide a comprehensive overview of our RNAscope in situ hybridization (ISH) assay services, as well as our quantitative image analysis capabilities for deep spatial biology insights.
Join us to gain insights about how we are advancing research and drug development with global partners in academia, biotech, and biopharma. You will learn more about study examples in key research areas including oncology and neuroscience with key applications in cell and gene therapy, single-cell RNAseq validation, biomarker validation, and more.
ACD’s Professional Assay Services (PAS) is the only CRO specialized in RNAscope, BaseScope™ miRNAscope™ and RNAscope™ Plus smRNA ISH services with consistent and reliable results. We provide tissue-based and cell specific analysis of targets and biomarkers with fast turnaround times.
- Spatial distribution of biomarkers in various tissues and solid tumors with RNAscope assays
- AAV vector detection and quantification with transgene expression in intact tissues
- Detection and tissue distribution of therapeutic oligonucleotides and small RNAs
- Visualization and quantification of CAR/TCR T cell infiltration and activation
- Detection of splice variants, point mutations and short target sequences with BaseScope assay.
- Simultaneous co-detection of RNA and protein biomarkers with ISH + IHC/IF workflows
- Quantitative approaches to image analysis
- Quality-controlled tissue bank for TMAs, solid tumors, diseased and normal human tissues
- Specific and sensitive biomarker validation to accelerate translation of assays into the clinic.
